US Vice President Kamala Harris did not mention plans for lowering prescription drug pricing in her speech accepting the Democratic party nomination as candidate for president 22 August, which might signal a cooling in the political rhetoric around further reforms.
Key Takeaways
-
Democratic presidential nominee Kamala Harris did not refer to drug pricing reform in her speech at the party convention last night, nor did Republican nominee Donald Trump at his convention last month.
-
Passage of the drug pricing reforms in the Inflation Reduction Act may have reduced the appeal of highlighting drug pricing reforms on the campaign trail
Granted the speech was light on any policy specifics in general